Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. 10:00 ET from Amplion Inc. BEND, Ore., May 4, 2016 /PRNewswire/...
Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. BEND, OR – May 3, 2016 – Amplion Inc., publisher of...
In mid-2015 we worked hard to add a new source of evidence for biomarkers: Laboratory Developed Tests, or LDTs. This was a huge milestone for Amplion. We successfully used our technology to identify biomarkers in a new information source very quickly without...
Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. 10:00 ET from Amplion Inc. BEND, Ore., May 4, 2016 /PRNewswire/...
Last week our chart of the week was a look at the total number of clinical trials started annually that include biomarkers, with a projection out to 2020. The hockey stick shape of the growth rate was striking, so much so that we decided to follow-up and ask...
